Inhalant use among incarcerated adolescents in the United States: prevalence, characteristics, and correlates of use.
about
Inhalant use and inhalant use disorders in the United StatesA survey of inhalant use disorders among delinquent youth: prevalence, clinical features, and latent structure of DSM-IV diagnostic criteria.Inhalant use, inhalant-use disorders, and antisocial behavior: findings from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).Item response theory analysis of DSM-IV criteria for inhalant-use disorders in adolescents.Exploring racial/ethnic differences in substance use: a preliminary theory-based investigation with juvenile justice-involved youth.Nitrous oxide inhalation among adolescents: prevalence, correlates, and co-occurrence with volatile solvent inhalationSubtypes of adolescent sedative/anxiolytic misusers: A latent profile analysisPharmacological classification of the abuse-related discriminative stimulus effects of trichloroethylene vapor.Preliminary Support for Multidimensional Treatment Foster Care in Reducing Substance Use in Delinquent Boys.Prescription drug misuse among antisocial youths.Helium inhalation in adolescents: characteristics of users and prevalence of use.The abused inhalant toluene differentially modulates excitatory and inhibitory synaptic transmission in deep-layer neurons of the medial prefrontal cortex.The prevalence and clinical significance of inhalant withdrawal symptoms among a national samplePatterns of Inhalant Use among Incarcerated Youth.Substance abuse among Iranian high school students.Initiation of alcohol, marijuana, and inhalant use by American-Indian and white youth living on or near reservations.Interventions for inhalant abuse among First Nations youth.Perceived risk of harm and intentions of future inhalant use among adolescent inhalant usersNeurochemical changes after acute binge toluene inhalation in adolescent and adult rats: a high-resolution magnetic resonance spectroscopy study.Volatile substance misuse in the United States.Volatile substance misuse : clinical considerations, neuropsychopharmacology and potential role of pharmacotherapy in management.Prevalence and assessment of traumatic brain injury in prison inmates: A systematic PRISMA review.Ataxia with Parkinsonism and dystonia after intentional inhalation of liquefied petroleum gasInhalation of computer duster spray among adolescents: an emerging public health threat?Suicide ideation and attempts among inhalant users: results from the national epidemiologic survey on alcohol and related conditions.Drug consumption among medical students in São Paulo, Brazil: influences of gender and academic year.Inhalants as intermediate drugs between legal and illegal drugs among middle and high school students.Nitrite inhalant abuse in antisocial youth: prevalence, patterns, and predictors.Assessing empathy in antisocial youth: factor analytic and validation findings.Crack users show high rates of antisocial personality disorder, engagement in illegal activities and other psychosocial problems.Persistent cognitive and morphological alterations induced by repeated exposure of adolescent rats to the abused inhalant toluene.Two cases of acute propane/butane poisoning in prison.An examination of information-processing skills among inhalant-using adolescents.Volatile Substance Misuse: Toward a Research AgendaDesistance motivations among adolescent inhalant users: Latent class and latent profile analysesEntre as asperezas do cotidiano e o brilho fácil: o manejo cotidiano do uso prejudicial de drogas
P2860
Q24635208-7039286D-AAE3-48D6-91DA-C809BB49289EQ33415716-CF83C7C5-3EDA-4331-BF9C-B32AE1E51182Q33739463-3F865C22-89E6-4CB4-9009-641C162212B9Q33922274-97C75645-9156-4F3B-BC51-8F83877BA87BQ33994073-E9B3ECF4-E4CC-48E9-A39F-39D3F3C8180FQ34065340-C0809F19-4274-4C0B-AD3B-C12C58EB8129Q34087203-76CCAB8B-48DD-4095-87B6-15A03F59A53BQ34139521-B831509B-44B1-40F7-BF7D-A7D0A48015ABQ34193442-AEF46B79-B862-4214-BB92-C3D46C32D9DBQ34248213-DA6CC5FA-F4BF-4A35-B0CA-FE01EAD20680Q34330833-190717D2-4A31-4C1D-8FBA-45356A0385AEQ34988464-ED9CE362-C599-443C-B0E7-669FC334A49CQ35068682-1890E42C-A64B-42A0-B608-EBE4CA3C66C6Q35762649-96FCD101-3032-4B53-9EF8-B80C97D958A4Q35776882-0B050CA7-1558-4D0B-BE88-1B0B4C16AE26Q36108262-1922990A-621E-4ED5-842F-2B501DCEEBB3Q36251845-745248B9-C546-42E8-A17A-6AFEE72E896FQ36911651-28300D85-B4B3-4028-A752-CC92E3606B36Q37408351-CA9FD791-795C-41F8-BEAC-9EF54FC701D2Q37879125-91F3B7B5-32D6-4EF6-BA52-4568D352F60AQ38047216-4908CF56-BD36-4DE2-96A1-F03B4B915242Q38916199-6809A3E0-021B-4BD2-AB29-71808C060B39Q40542946-4A333F28-D526-45EF-847A-48AFA3563528Q42964369-61783EA1-7AA6-44D0-A4BF-CA71AD19D515Q43013102-C283D092-12C8-4794-9B1B-5BF1B6CD3D33Q43270516-510558A7-B559-4875-9729-81F88217AC36Q43452993-1B3E0717-9112-4A9B-B1DD-5374BB7050F5Q43714414-345E72B7-255F-4322-873F-A429CB22E4C9Q44230666-7A0D701B-1723-42A9-A2C7-6E95A5BFAC1CQ45381353-9D712C88-94CF-43E3-843F-81917FD90797Q48190211-928F92F4-0C9D-426C-BC74-18155243DBBBQ48790043-6225C662-90CF-41AE-B60A-2071A900A350Q51001692-59B9970F-9750-4BDD-9A27-876147848897Q58181512-09CF90DE-2B28-4F68-825A-B995E81D5684Q58245715-8C36C5BE-1A66-4BD9-ACF3-520728B95B9AQ58427736-81649967-B962-453F-B3CD-5EE7572C2BBF
P2860
Inhalant use among incarcerated adolescents in the United States: prevalence, characteristics, and correlates of use.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Inhalant use among incarcerate ...... istics, and correlates of use.
@en
Inhalant use among incarcerate ...... istics, and correlates of use.
@nl
type
label
Inhalant use among incarcerate ...... istics, and correlates of use.
@en
Inhalant use among incarcerate ...... istics, and correlates of use.
@nl
prefLabel
Inhalant use among incarcerate ...... istics, and correlates of use.
@en
Inhalant use among incarcerate ...... istics, and correlates of use.
@nl
P2093
P1476
Inhalant use among incarcerate ...... ristics, and correlates of use
@en
P2093
Linda B Cottler
Matthew O Howard
Michael G Vaughn
Robert L Balster
P304
P356
10.1016/J.DRUGALCDEP.2007.08.023
P50
P577
2007-11-05T00:00:00Z